Technical Analysis for OVID - Ovid Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 1.77 -1.12% -0.02
OVID closed down 1.12 percent on Thursday, April 18, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical OVID trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
20 DMA Resistance Bearish -1.12%
Volume Surge Other -1.12%
Bollinger Band Squeeze Range Contraction -1.12%
Outside Day Range Expansion -1.12%
20 DMA Resistance Bearish -3.28%
Bollinger Band Squeeze Range Contraction -3.28%
20 DMA Resistance Bearish -3.28%

Older signals for OVID ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Ovid Therapeutics Inc. (Ovid) is a biopharmaceutical company. The Company is engaged in developing medicines for patients and families living with rare neurological disorders. Its lead drug candidate is OV101. The Company’s second lead drug candidate is OV935. OV101 (gaboxadol) is a delta-selective GABAA receptor agonist. Ovid is developing OV101 for use in both Angelman syndrome and Fragile X syndrome to potentially restore tonic inhibition and relieve several of the symptoms of these disorders. Ovid has initiated the Phase II STARS trial of OV101 in adults with Angelman syndrome and a Phase I trial in adolescents with Angelman syndrome or Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies.
Biopharmaceutical Organ Systems Disorders Neurological Disorders Epilepsy Genodermatoses Sedatives Anticonvulsants Fragile X Syndrome Syndromes
Is OVID a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.45
52 Week Low 1.66
Average Volume 392,773
200-Day Moving Average 4.6773
50-Day Moving Average 2.0042
20-Day Moving Average 1.8385
10-Day Moving Average 1.835
Average True Range 0.149
ADX 18.34
+DI 21.1223
-DI 21.8225
Chandelier Exit (Long, 3 ATRs ) 1.753
Chandelier Exit (Short, 3 ATRs ) 2.107
Upper Bollinger Band 1.9384
Lower Bollinger Band 1.7386
Percent B (%b) 0.16
BandWidth 10.867555
MACD Line -0.0651
MACD Signal Line -0.0755
MACD Histogram 0.0104
Fundamentals Value
Market Cap 43.54 Million
Num Shares 24.6 Million
EPS -4.85
Price-to-Earnings (P/E) Ratio -0.36
Price-to-Sales 0.00
Price-to-Book 1.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.95
Resistance 3 (R3) 1.95 1.88 1.92
Resistance 2 (R2) 1.88 1.84 1.89 1.91
Resistance 1 (R1) 1.83 1.81 1.80 1.83 1.90
Pivot Point 1.76 1.76 1.75 1.77 1.76
Support 1 (S1) 1.71 1.72 1.68 1.71 1.64
Support 2 (S2) 1.64 1.69 1.65 1.63
Support 3 (S3) 1.59 1.64 1.62
Support 4 (S4) 1.59